IDiyas

For the Inventor, By the Inventor

Mannheim, Germany

Andrea Horsch

USPTO Granted Patents = 26 


 

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 67(Granted Patents)


Location History:

  • Lucerne, CH (2017 - 2021)
  • Lucern, CH (2022)
  • Mannheim, DE (2009 - 2023)

Company Filing History:

goldMedal26 out of 1,648 
 
Roche Diagnostics Operations, Inc.
 patents

Years Active: 2009-2023

where 'Filed Patents' based on already Granted Patents

26 patents (USPTO):
1. 11719710 - GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients (2023-08-08),
2. 11397187 - IGFBP7 for prediction of risk of AKI when measured prior to surgery (2022-07-26),
3. 11047865 - Troponin and BNP based diagnosis of risk patients and cause of stroke (2021-06-29),
4. 10942175 - Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure (2021-03-09),
5. 10732188 - NT-proANP and NT-proBNP for the diagnosis of stroke (2020-08-04),
6. 9983213 - Identification of subjects being susceptible to anti-angiogenesis therapy (2018-05-29),
7. 9638700 - NT-pro ANP and SFlt-1 for the differentiation between circulatory and ischemic events (2017-05-02),
8. 9535073 - Prediction and recognition of acute kidney injury after surgery (2017-01-03),
9. 8771961 - Monitoring myocardial infarction and its treatment (2014-07-08),
10. 8663941 - Method for diagnosing and monitoring cardiac ischemia in patients with acute chest pain and without myocardial infarction (2014-03-04),
11. 8501155 - Biochemical markers for acute pulmonary embolism (2013-08-06),
12. 8497095 - Biochemical markers for acute pulmonary embolism (2013-07-30),
13. 8486706 - L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy (2013-07-16),
14. 8440463 - Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1 (2013-05-14),
15. 8361800 - Diagnostic means and methods using troponin T and NT-proBNP (2013-01-29),

Title: Unveiling Innovator Andrea Horsch: Leading the Way in Laboratory Diagnostics

Introduction: Andrea Horsch, a pioneering inventor based in Mannheim, Germany, has significantly impacted the field of laboratory diagnostics with her groundbreaking work and numerous patented innovations.

Latest Patents:

1. GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients: Andrea's innovative approach focuses on determining a patient's risk of acute kidney injury post-surgery by detecting specific biomarkers like GDF-15 and troponin T. This method holds promise for enhancing patient care and outcomes in surgical settings.

2. IGFBP7 for prediction of risk of AKI when measured prior to surgery: Andrea's method involves predicting a patient's risk of acute kidney injury during or after surgery by measuring the biomarker IGFBP7 in body fluid samples obtained before the procedure. This cutting-edge technique could revolutionize pre-operative risk assessment and personalized healthcare.

Career Highlights: Andrea Horsch is a key contributor at Roche Diagnostics Operations, Inc., a leading player in the diagnostics industry. Her innovative spirit and dedication to advancing medical technologies have solidified her reputation as a trailblazer in the field.

Collaborations: Alongside accomplished coworkers Georg Hess and Dietmar Zdunek, Andrea has collaborated on various projects, fostering a dynamic and collaborative work environment at Roche Diagnostics Operations, Inc.

Conclusion: Andrea Horsch's remarkable achievements in laboratory diagnostics underscore her commitment to pushing the boundaries of medical innovation. Her patented inventions hold immense potential for transforming healthcare practices and improving patient outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…